Skip to main content
Clinical Trials/IRCT2017053034222N1
IRCT2017053034222N1
Recruiting
Phase 3

Effect of Calcitriol supplementation on the severity of fatty liver, inflammatory and metabolic biomarkers in patients with non-alcoholic fatty liver with different genotypes of vitamin D receptor

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on-Alcoholic Fatty Liver disease (NAFLD).
Sponsor
Ahvaz Jundishapur University of Medical Sciences
Enrollment
160
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\- 60 years
  • Presence of NAFLD diagnosed by Fibroscan elastography
  • Increased alanine transaminase (\> 40 U/L)
  • BMI below 35

Exclusion Criteria

  • Alcohol consumption greater than 20 g per day
  • pregnancy; lactation
  • viral or autoimmune hepatitis
  • hereditary hemochromatosis
  • Wilson's disease
  • a1\-antitripsin deficiency
  • malabsorption syndromes
  • consumption of hepatotoxic drugs
  • high doses of synthetic estrogens
  • hypothyroidism and Cushing's syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials